UTI Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8689 Cr | ₹1187 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 28% |
| Expense Ratio | 1.81 | 2.25 |
| Manager | Sailesh Raj Bhan | Kamal Gada |
| ISIN Code | INF204K01968 | INF789F01695 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | -3.66% | -2.99% |
| 6 Month | 7.39% | 13.17% |
| 1 Year | 21.43% | 31.36% |
| 3 Year | 19.27% | 20.3% |
| 5 Year | 25.83% | 25.72% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 14.69% | 24.85% |
| 3 Year | 27.2% | 30.93% |
| 5 Year | 22.9% | 24.08% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 17.79% | 10.93% |
| 3 Year | 20.87% | 15.88% |
| 5 Year | 20.18% | 14.02% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 14.36% | 14.3% |
| Sharp | 0.78% | 0.62% |
| Beta | 0.87% | 0.94% |
| Alpha | 1.67% | 0.78% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Sailesh Raj Bhan | Kamal Gada |
| Total AUM | ₹96086 Cr | ₹870 Cr |
| Fund Manage | 5 | 1 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 4.4 | 1.53 |
| Large Cap | 45.96 | 32.81 |
| Mid Cap | 27.12 | 26.59 |
| Small Cap | 22.52 | 39.04 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 4.4 | 1.53 |
| Pharmaceuticals & Biotechnology | 75.86 | 75.33 |
| Healthcare Services | 17.38 | 21.22 |
| Retailing | 2.36 | - |
| Healthcare Equipment & Supplies | - | 0.85 |
| Insurance | - | 1.04 |
Top Comparisons
Kotak ELSS Tax Saver Fund-Scheme-Growth
3Y Returns14.05%
Motilal Oswal ELSS Tax Saver Fund (MOFLTE) - Regular Plan - Growth Option
3Y Returns21.58%
Mahindra Manulife Equity Savings Fund - Regular Plan - Growth
3Y Returns7.8%
DSP Equity Savings Fund - Regular Plan - Growth
3Y Returns9.11%
HDFC Large and Mid Cap Fund - Growth Option
3Y Returns18.52%
SBI Large & MIDCap Fund- Regular Plan -Growth
3Y Returns14.73%
ITI Arbitrage Fund Regular - Growth
3Y Returns5.39%
SBI Arbitrage Opportunities Fund - Regular Plan - Gr
3Y Returns6.55%